Smith & Nephew Share Discussion Threads

[philanderer] 21/10/2019 23:42

Berenberg keeping their rating unchanged today ... 'buy' tp 2250p

..as do Shore Cap with their 'sell'

[kknight01] 21/10/2019 21:50

The company is certainly strong and I think what Namal brought was some guts to go out and start buying up small med tech companies to bolster the portfolio which if definitely the right way to go. I do hope his successor continues the momentum, sales are not going to diminish due to his departure, I think it is safe to day that medical device manufacturers are a good buy, with people living longer and the demand on healthcare increasing. The majority of the share price valuation was based on Namal's attitude to business and believe it will recover in time. In my opinion, we have an excellent t buying opportunity ahead and like you said, could very well be snapped up by a bigger fish any time.

[steeplejack] 21/10/2019 10:46

£14 ?.....The chart would suggest as much.Currency factors are now moving against overseas earners.

It’s difficult.It’s one of those situations where you can understand why a stock is falling but don’t know whether to sell and buy back in lower (easier said than done) or simply buy more on the basis that the company is fundamentally sound and doing well.I’m inclined to buy more on the basis that the company is doing well and as instrumental as Namal might is/has been in the company’s success,one man is not irreplaceable.I purchased shares because of the company’s niche market position and the undoubted attractiveness of its product range not the strength of management per se.Also,as we all know,this company has been stalked by predators before and will be again.I don’t see this company being independent in three years time.

[kknight01] 21/10/2019 10:36

Where the decline will stop no one knows but with a Q3 results announcement due soon, and depending how well Q3 has been, these could go back to 2018 levels of £14.

[kknight01] 21/10/2019 10:34

Financial times have put some detail around this....... Namal wanted to move listing from UK to US so he could boost his pay (with the company listed in the UK there are restrictions on exec salary). Guessing the board disagreed and he decided to leave. All comes down to money in the end, shame really as I know a lot of people believed in Namal to turn this great company into something greater.

[steeplejack] 21/10/2019 09:55

Smith & Nephew"Can anything stop the exodus of FTSE 100 chief executives in 2019? The numbers have now been bolstered to the point where these departing CEOs could almost cobble together an 11-a-side football match as Smith & Nephew's Namal Nawana steps down."Australian Nawana has only been in post for 18 months but has already helped revive the share price with a new strategy."This culminated in re-organising the business into three global franchises: orthopaedics, sports medicine and advanced wound management."The market responded positively to this simplified structure, which reduced duplication of effort and made reporting responsibilities clearer with better accountability."There appears to be a pretty simple reason Nawana is leaving – pay. It became apparent over the summer that the company was looking for ways to increase its head honcho's remuneration with apparent discussions about a move to a US listing to escape an increasing backlash in the UK towards excessive executive pay."The fear will be that this revamp of the business will be derailed by Nawana's departure despite efforts to allay these concerns – with internal candidate Roland Diggelmann stepping up to the top job and Nawana staying to smooth the transition until the end of the year."Diggelmann faces a tricky task of balancing the need for continuity with a likely ambition to bring his own ideas to the role."

[steeplejack] 21/10/2019 09:04

Market doesn’t like the fact that Namal Nawana is stepping down and probably doesn’t appreciate the lack of detail accompanying that announcement.Then they’re appointing a non executive as a replacement which strikes one as unusual.

[steeplejack] 21/10/2019 08:58

CEO change.

[croquetman] 21/10/2019 08:50

Why such a big drop?

[adamb1978] 19/8/2019 21:08

How much of the share price performance is simply FX driven? They report in $ and I suspect price in $ meaning having the £ head to the low 1.20s vs the $ helps them materially - its all extra revenue with no cost against it so falls straight through to the bottom line

[broadwood] 01/8/2019 10:21

For years a sleeping giant.

New CE has woken him up.

Patience being rewarded.

[robert topgun] 31/7/2019 21:24

True! I’ll probably regret it but
I’ve sold paying down my mortgage
Held for 5 years

[abbynat] 31/7/2019 21:04

re rob topgun.
it depends on what you paid for them! its good to take a profit. i get the feeling they may go down just a bit, but, this co seems to be heading to the top and getting bigger and bigger, and so should the price. i suppose they appear expensive, they deserve to be and i reckon there is a lot more mileage to come!

[robert topgun] 30/7/2019 20:47

I’m getting tempted to sell, flown up these.

[kknight01] 30/7/2019 20:17

Results tomorrow this could easily get to 1950.

[kknight01] 23/7/2019 08:20

Results due 31st. Gonna smash through 18 easily. Predicting a huge acquisition on the way! Namal is the first CEO this company has had with some balls.

[abbynat] 15/6/2019 16:56

smashed thru £17.00 barrier! incredible!
is it continuing to go up, slowly and surely or is it peak time and slowly and quietly
down? this share historically has its cycles, but, under the new team its poss it will continue up and up!

[broadwood] 11/6/2019 10:36

- Medical technology company Smith & Nephew said it had agreed to acquire Switzerland-based provider of optical tracking technology Atracsys Sarl, for an undisclosed sum.

Atracsys Sarl's technology was used in computer-assisted surgery and its optical tracking camera would assist Smith & Nephew's digital surgery and robotic ecosystem, the company said.

The acquisition was expected to complete during the third quarter of 2019.

[kknight01] 11/6/2019 08:54

Smith and nephew acquires Atracsys Sarl. Swiss based optical tracking technology used in computer aided surgery. Nice!

[abbynat] 04/6/2019 20:50

oh dear! a price drop! i am being sarcastic here.

[kknight01] 28/5/2019 13:40

No idea where support lies for this now! I thought 15.50 but it just keeps on going!

[abbynat] 24/5/2019 21:29

there seems to be no stopping this train!

[kknight01] 16/5/2019 03:20

Products....... leadership....... acquisitions. Sold entire holding for 1620. Just waiting for a pull back to the 1500's to pile it all back in!

[abbynat] 15/5/2019 21:08

hello, hello. is anybody there?
there seems no stopping to this share!
is it the share buyback or sheer positive company products and performance?

[steeplejack] 02/5/2019 09:50

Excellent start to the year.